MEASUREMENT OF BUSULFAN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：63

作者：

HENNER, WD ^{[1
]}

FURLONG, EA ^{[1
]}

FLAHERTY, MD ^{[1
]}

SHEA, TC ^{[1
]}

PETERS, WP ^{[1
]}

机构：

[1] DUKE UNIV,SCH MED,DEPT MED,DURHAM,NC 27710

来源：

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1987年 / 416卷 / 02期

关键词：

D O I：

10.1016/0378-4347(87)80531-5

中图分类号：

O65 [分析化学];

学科分类号：

070302 [分析化学]; 081704 [应用化学];

摘要：

引用

页码：426 / 432

页数：7

共 16 条

[1]

ANTIN JH, 1985, BLOOD, V66, P597

[2]

BESCHORNER WE, 1980, AM J PATHOL, V99, P369

[3]

PRETRANSPLANT CONDITIONING WITH BUSULFAN (MYLERAN) AND CYCLOPHOSPHAMIDE FOR NONMALIGNANT DISEASES - ASSESSMENT OF ENGRAFTMENT FOLLOWING HISTOCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

BLAZAR, BR ;

RAMSAY, NKC ;

KERSEY, JH ;

KRIVIT, W ;

ARTHUR, DC ;

FILIPOVICH, AH .

TRANSPLANTATION, 1985, 39 (06) :597-603

[4]

CHAMPLIN RE, 1985, BLOOD, V65, P1039

[5]

DUNN CDR, 1974, EXP HEMATOL, V2, P101

[6]

BUSULFAN KINETICS [J].

EHRSSON, H ;

HASSAN, M ;

EHRNEBO, M ;

BERAN, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :86-89

[7]

BINDING OF BUSULFAN TO PLASMA-PROTEINS AND BLOOD-CELLS [J].

EHRSSON, H ;

HASSAN, M .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (10) :694-696

[8]

EHRSSON H, 1983, J PHARM SCI, V72, P1203, DOI 10.1002/jps.2600721024

[9]

THE PROBLEM OF PERMANENT BONE-MARROW DAMAGE AFTER CYTO-TOXIC DRUG-TREATMENT [J].

LOHRMANN, HP .

ONCOLOGY, 1984, 41 (03) :180-184

[10]

MARSH JC, 1976, CANCER RES, V36, P1853

← 1 2 →